Bifido Co

Bifido Co EBITDA per Share

The EBITDA per Share of Bifido Co (238200.KQ) as of Oct 28, 2026 is 171.53 KRW. In the previous year, EBITDA per Share was -757.92 KRW — a change of -122.63% (higher).

EBITDA per Share

171.53KRW

YoY

-122.63%

Last updated:

EBITDA per Share of Bifido Co is 2025 171.53 KRW. EBITDA per Share of Bifido Co was 2024 -757.92 KRW. It decreases by -122.63% higher compared to the previous year.

The Bifido Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
433.30 KRW
Jan 1, 2019
187.02 KRW
Jan 1, 2020
-91.65 KRW
Jan 1, 2021
-107.66 KRW
Jan 1, 2022
176.53 KRW
Jan 1, 2023
-19.10 KRW
Jan 1, 2024
-757.92 KRW
Jan 1, 2025
171.53 KRW
The Bifido Co EBITDA per Share history
YEAREBITDA per ShareYoY
171.53KRW-122.63%
-757.92KRW+3,868.39%
-19.10KRW-110.82%
176.53KRW-263.97%
-107.66KRW+17.47%
-91.65KRW-149.00%
187.02KRW-56.84%
433.30KRW-15.09%
510.28KRW+44.53%
353.07KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Bifido Co Stock analysis

What does Bifido Co do? Bifido Co. Ltd. generates revenue through the sale of probiotics health functional foods for various age groups, including infants, kids, adults, and women, under the brand ZIGUNUK BIFIDUS. The company also sells supplementary pet feeds and cosmetics such as creams and serums. Additionally, Bifido Co. Ltd. produces and sells raw materials for probiotics and fermented ginseng to other manufacturers. The target customers for ZIGUNUK BIFIDUS products are consumers seeking health-focused probiotic solutions across different life stages. Pet feed buyers include pet owners and pet care businesses. Cosmetics buyers are individuals interested in skincare products containing probiotics. Raw material clients are manufacturers in the probiotics and fermented ginseng industries. ZIGUNUK BIFIDUS is the primary brand for health functional foods, while the company's supplementary pet feeds and cosmetics are sold under their own brand names. The raw materials for probiotics and fermented ginseng are sold directly to manufacturers without specific branding. Bifido Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bifido Co stock

EBITDA per Share of Bifido Co is 171.53 KRW in 2025.

EBITDA per Share of Bifido Co changed from -757.92 KRW to 171.53 KRW, representing a -122.63% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Bifido Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Bifido Co

All Key Metrics — Bifido Co